Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated just now

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. A druggable chromatin vulnerability in suppressive neutrophils restores antitumor immunity
    F. Yang, Y. Bao, Y. Qiao +29
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. Systemic tumor-cell reprogramming converts solid tumors into in situ biofactories for immunotherapy
    S. Wang, Q. Xu, M. Wu +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. PGG Enhances Olaparib Efficacy via cGAS-STING Signaling and Sensitizes Triple-Negative Breast Cancer to PD- L1 Blockade
    h. S. Liu, X. Li, c. X. Yang +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. Can Molecular Response Redefine Organ Preservation in Rectal Cancer? From Clinical Complete Response to Precision Watch-and-Wait.
    Orçun Yalav, Ali Yıldırım, Natavan Guliyeva +5
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textOncologyEurope PMC
  5. Functional Deconstruction of AC-T Chemotherapy Reveals Interindividual Heterogeneity and Independent Drug Action in Breast Cancer.
    Lucas Damé Simões, Giulia Luiza Santos, Priscila Oliveira de Carvalho +17
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  6. OVO-like Proteins in Cancer, Immunity, and Inflammation.
    Shuxian Huang, Genjian Hu, Hao Lan +1
    CellsPeer-reviewedCC BYFull textOncologyEurope PMC
  7. Uncovering Immune Cell-Specific lncRNAs as Anti-PD-1 Response-Associated Markers in Breast Cancer.
    Clayton Voidelo, Thalita Maria do Nascimento, Regiane Stafim da Cunha +2
    International journal of molecular sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Enrichment-Free Rare Cell Profiling in Pediatric Osteosarcoma Reveals a Circulating Cell Population Associated with Relapse-Free Survival
    Stephanie N. Shishido, Siddhant Chaudhary, Ian Ward +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  9. The Landscape of Tumor Dissemination in Leptomeningeal Disease: Mapping CTC Plasticity and Regional Heterogeneity Across Blood and CSF Compartments
    Stephanie N. Shishido, Baishali Chaudhuri, Vidur Mushran +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  10. PLIN2 links lipid droplets to GRP78-mediated GPX4 stabilization to suppress neuronal ferroptosis
    Qianruo Wang, Baokun Sui, Jiaxin Zheng +5
    Cell InsightPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  11. Cancer Neuroscience: Establishing a home in Neuro-Oncology
    Shawn L Hervey-Jumper, Michelle Monje, Frank Winkler +1
    Neuro-OncologyPeer-reviewedPublisher termsFull textOncologyPMC
  12. Glioma and ependymoma through the lens of brain development, stem cells, and plasticity
    Costanza Lo Cascio, Antoni Martija, Mariella G Filbin +1
    Neuro-OncologyPeer-reviewedPublisher termsFull textOncologyPMC
  13. Integrated EBV and host DNA methylation profiling identifies distinct candidate EBV–host junction patterns in chronic active EBV infection
    Ran Wang, Linlin Zhang, Dilara Dilmurat +8
    Microbiology SpectrumPeer-reviewedCC BY 4.0Full textOncologyPMC
  14. Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review
    Tessa Robinson, Marian Saab, Lily Thao Nguyen +4
    Clinical GeneticsPeer-reviewedCC BY 4.0Full textOncologyPMC
  15. Multipronged enhancement of CART cell activity against ROR1 neoantigen by inhibition of H3K27 methyltransferase EZH2
    Shengchun Wang, Cosimo Lobello, Pradeep K. Gupta +21
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  16. Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission
    Raffaella Casolino, Joaquı́n Mateo, Elisabeth G E de Vries +53
    The Lancet OncologyPeer-reviewedLicence not stated10 citedOncologyOpenAlex
  17. Disruption of the ARID1A-containing SWI/SNF complex reprograms tumor-associated macrophages and enhances immunotherapy response
    H. M. McRae, K. M. Nguyen, Q. Vallmajo-Martin +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  18. Palmitate-activated IRE1-XBP1 signaling limits DNA damage and is associated with H2A.X-linked DNA damage response transcripts in triple-negative breast cancer cells
    K. Y. Chen, E. Gouin, A. Erickson +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  19. Deciphering the association of spatial landscapes of DCIS with recurrence as invasive breast cancer
    N. Graham, A. K. Turnbull, C. Martinez-Perez +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  20. Pathway-wide base editing charts chemical-genetic interactions in MAPK signaling
    J. Woods, C. X. Y. Hu, D. M. Jang +6
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  21. BLTP3A dysfunction unleashes lysosomal stress-induced antitumor immunity through STING
    E. S. Hosseini, S. Wang, M. Arabzadeh +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  22. Cooperativity through Allee Effects drives growth of diffuse midline gliomas impacting the optimal scheduling of therapeutic interventions
    H. Tari, K. Kessler, E. Izquierdo +2
    bioRxivPreprintCC BYFull textOncologybioRxiv
  23. Multiplatform Genomic and Transcriptomic Profiling of Breast Carcinomas with an Invasive Micropapillary Component.
    Boram Lee, Je-Gun Joung, Woong-Yang Park +2
    GenesPeer-reviewedCC BYFull textOncologyEurope PMC
  24. The Psychosocial Burden of the 'Lazarus Effect': A Systematic Review of Survivor Guilt, Identity Shift, and Discontinuation Anxiety in Exceptional Responders to Cancer Immunotherapy.
    Johanna Alcívar Ponce, Wilson Alexander Zambrano Vélez, Marianela Silva Sánchez +1
    Diseases (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  25. Paired Tissue and Plasma Comprehensive Genomic Profiling in Advanced Solid Tumors: A Retrospective Study from India.
    Ankur Bahl, Nitesh Rohatgi, Suman S Karanth +3
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC